New Publication
Homeopathy in Intensive Care
and Emergency Medicine
Homeopathy First Magazine
Best Vitamin C Drink 
Learn More With Caralyn 


Homeopathy World Community

Creating Waves of Awareness

Dear Friends - Would you say that using carcinosin or any other similar homeopathic remedy could act as a universal remedy for those who have been diagnosed, contracted or potential candidates for cancer? 

  • Allopathy has proposed that the next "miracle drug" is around the corner. Much like search for the unifying factor to the universe, perhaps one trigger will cause or eliminate the expression of chaotic cell growth and loss of individualization.  Researchers seek one drug to cure human breast, ovary, colon, bladder, brain, liver and prostate tumor.

  • Once again, researchers look to the 'antibody' theory, which would be the indicator that the immune system has started to work effectively and with energy to remove abnormal growth. This reasoning has been used to show the effectiveness of vaccines. 

  • How would this work? Tumor cells do not show signs of apoptosis, the process of programmed cell death (PCD) when cells grow without differentiation. Homeopathically, we might consider that tumors are the body's self preservation method to encapsulate improper growth and dysfunction within the organism. We often see trees with tumors that live long lives. Many have hypothesized that living in a toxic world and eating toxic foods would stimulate the body to wall off many of the harmful chemicals and substances into tumor growths.

  • Recent work with mice has shown that an antibody would signal proper apoptosis, in other words, tumor cells would be removed from the body, since they show uncontrolled out-of-the ordinary cell grow.

Healthy cells contain their own protein marker to indicate the immune system not to attack them as they circulate throughout the body. Cancer researcher, Irving Weissman, concluded all cancer cells in his test results also contained this protein marker, CD47 to trick the body into preventing apoptosis. Further research using an antibody [anti-CD47] to block the action of CD47 protein on cancer cells resulted in the death of these cancer cells. 

Invitro experiments in a petri dish of mouse tumor cells and macrophages using anti-CD47 showed promise. Next, the team transplanted human tumors into the feet of mice, where tumors can be easily monitored. When they treated the rodents with anti-CD47, the tumors shrank and did not spread to the rest of the body.

In mice given human bladder cancer tumors, for example, 10 of 10 untreated mice had cancer that spread to their lymph nodes. Only one of 10 mice treated with anti-CD47 had a lymph node with signs of cancer.

Besides the disappearance of cancer, many of the implanted bladder, colon and breast tumors reduced in size considerably. The duration of remission lasted up to 4 months. 

Noted was the loss of blood cells that carry the CD47 marker when mice were given anti-CD47 antibody factor. However, the mice also increased production of new blood cells.


Many questions must be asked, since the in vitro environment differs considerably from the human in vivo environment. The next step is phase 1 human trials.

  • Another important question, Jacks says, is how CD47 antibodies would complement existing treatments. "In what ways might they work together and in what ways might they be antagonistic?" Using anti-CD47 in addition to chemotherapy, for example, could be counterproductive if the stress from chemotherapy causes normal cells to produce more CD47 than usual.

Views: 842

Reply to This

HWC Partners


© 2019   Created by Debby Bruck.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Related Posts Plugin for WordPress, Blogger...